Circulate News and Research

Oct 9, 2025

Microplastics Are in Our Blood—Why Aren’t Federal Regulators Acting?

Mounting research demands urgency — but regulation has yet to follow.

Oct 4, 2025

Circulate Health Recognized Among Top 10 Longevity Breakthroughs of 2025

Awarded for excellence in longevity medicine and voted Best Innovation at the 2025 APLS Summit

Sep 29, 2025

Study Finds Coffee May Interfere With Antibiotics—Here’s What Doctors Say

Could your morning cup be sabotaging your medication?

Sep 14, 2025

Microplastics Are in Our Blood — Why Aren’t Federal Regulators Acting?

The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale.

Jul 4, 2025

Seattle startup Circulate Health raises $12M for pricey ‘blood-cleaning’ longevity service

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding.

Jul 1, 2025

Exclusive: Khosla Ventures backs startup selling ‘therapeutic plasma exchange’ at longevity clinics

Circulate Health, a startup offering a potential anti-aging procedure, has raised $12 million in seed funding led by Khosla Ventures, the companies told Endpoints News in exclusive interviews.

May 28, 2025

Circulate's TPE Trial Featured in The New York Times

One of the first trials examining plasma exchange for anti-aging in humans, published Tuesday in the journal Aging Cell, offers early evidence that it may be able to slow the biological breakdown that comes with age, even in otherwise healthy people.

May 13, 2025

Ziploc Faces a Class Action Lawsuit for Undisclosed Microplastic Risk. What You Need to Know

The company's misleading advertising exposed families to an undisclosed amount of microplastics without their knowledge.

Apr 18, 2025

The Circulate Microplastics Report

A comprehensive report on the Microplastic problem and how Circulate is working on finding a solution.

Mar 26, 2025

The Invisible Threat: Microplastics in the Human Body and the Promise of Therapeutic Plasma Exchange (TPE)

Circulate CEO Dr. Brad Younggren's Op-Ed published in Healthcare Business Today

Mar 22, 2025

The Longevity Business Is Booming—and Its Scientists Are Clashing

The antiaging movement has raced ahead amid fierce debates; critics of a grandfather of the field, Leonard Guarente, include former protégés and rivals.

Feb 14, 2025

Unlocking the Power of TPE with Dr. Brad Younggren

Dr. Fadul interviews Dr. Younggren on the Health & Hype Podcast

Aug 8, 2024

How Plasma Exchange Could Help Turn Back the Clock on Aging

Read a summary of and follow a link to The Circulate Trial research report.